Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06565416 · ClinicalTrials.gov registry record · NA

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

A NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of New Mexi.

Recruiting
Registry status
NA
Development phase
225
Enrollment target
3
Study locations

NCT06565416: Recruiting NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of New Mexi.

NCT06565416 is a NA study of Chronic Pain and Opioid Use Disorder that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 225 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06565416, a NA study of Chronic Pain and Opioid Use Disorder, is actively recruiting participants, sponsored by University of New Mexi.

RECRUITING
Registry status
NA
Development phase
225 participants
Enrollment target
3
Study locations

Study Summary

The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.

Primary Outcome

Derived from electronic medical records

Interventions

  • BEHAVIORAL Implementation Strategies

Study Locations (3)

California

  • Clinic Site A (blinded pending tribal approval) - Arcata

Minnesota

  • Clinic Site C (blinded pending tribal approval) - Minneapolis

Washington

  • Clinic Site B (blinded pending tribal approval) - Toppenish

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2023-06-01
Est. Completion 2028-07
Phase NA
University of New Mexi

76 total trials

What NCT06565416 shows while recruiting

NCT06565416 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (71% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Implementation Strategies is the first listed.

NCT06565416 reports a single indexed study location in California, Minnesota, Washington.

Frequently Asked Questions

What is clinical trial NCT06565416 about?

NCT06565416 is a clinical study titled "Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial". The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives...

What is the current status of trial NCT06565416?

This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2023-06-01. Estimated completion is 2028-07.

What conditions does trial NCT06565416 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder, Opioid Misuse.

What interventions are being tested in trial NCT06565416?

The interventions under investigation include: Implementation Strategies (BEHAVIORAL).

Who is sponsoring clinical trial NCT06565416?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06565416 being conducted?

This trial has 3 study locations across California, Minnesota, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06565416's enrollment target sits among peer trials

225 75th of 301 higher than 227 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06565416, the US trial registry maintained by the National Library of Medicine. NCT06565416 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.